Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 17, 2009
Patent Application Number
11154465
Date Filed
June 16, 2005
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and EGFR-targeted drugs.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
